Sunday, October 17, 2021

Bharat Biotech to begin paediatric trials of Covaxin from June – ET HealthWorld

Indian vaccine innovator Bharat Biotech International (BBIL), which developed the indigenous Covid-19 vaccine with Indian Council of Medical Research and the National Institute of Virology, will begin clinical trials of the vaccine on paediatrics from June 1.

The Hyderabad headquartered vaccine maker has recently received approvals from the drug regulator to carry out paediatric trials of the vaccine.

“It will be a trial on children aged 2-18 years,” said Raches Ella, Bharat Bio’s head-business development and international advocacy, addressing a Ficci Ladies Organisation (FLO) meeting in Hyderabad on Saturday.

“Kids vaccine trials of Bharat Biotech may get the license in the third quarter of this year.”

Further, Ella said the vaccine maker has also initiated the process to obtain the approval of the World Health Organisation (WHO) for Covaxin and expects the approval soon.

“A few of our products in the past got their approval. We expect approval for Covaxin by the end of Q3 or Q4,” said Raches Ella.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...